BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 28889371)

  • 1. Bone Marrow Stroma and Vascular Contributions to Myeloma Bone Homing.
    Moschetta M; Kawano Y; Sacco A; Belotti A; Ribolla R; Chiarini M; Giustini V; Bertoli D; Sottini A; Valotti M; Ghidini C; Serana F; Malagola M; Imberti L; Russo D; Montanelli A; Rossi G; Reagan MR; Maiso P; Paiva B; Ghobrial IM; Roccaro AM
    Curr Osteoporos Rep; 2017 Oct; 15(5):499-506. PubMed ID: 28889371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endosteal and Perivascular Subniches in a 3D Bone Marrow Model for Multiple Myeloma.
    Braham MVJ; Ahlfeld T; Akkineni AR; Minnema MC; Dhert WJA; Öner FC; Robin C; Lode A; Gelinsky M; Alblas J
    Tissue Eng Part C Methods; 2018 May; 24(5):300-312. PubMed ID: 29652626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloma plasma cells alter the bone marrow microenvironment by stimulating the proliferation of mesenchymal stromal cells.
    Noll JE; Williams SA; Tong CM; Wang H; Quach JM; Purton LE; Pilkington K; To LB; Evdokiou A; Gronthos S; Zannettino AC
    Haematologica; 2014 Jan; 99(1):163-71. PubMed ID: 23935020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiogenesis in multiple myeloma.
    Vacca A; Ria R; Reale A; Ribatti D
    Chem Immunol Allergy; 2014; 99():180-96. PubMed ID: 24217610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell autonomous and microenvironmental regulation of tumor progression in precursor states of multiple myeloma.
    Manier S; Kawano Y; Bianchi G; Roccaro AM; Ghobrial IM
    Curr Opin Hematol; 2016 Jul; 23(4):426-33. PubMed ID: 27101529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple myeloma as a model for the role of bone marrow niches in the control of angiogenesis.
    Ribatti D; Nico B; Vacca A
    Int Rev Cell Mol Biol; 2015; 314():259-82. PubMed ID: 25619720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA Barcoding Reveals Habitual Clonal Dominance of Myeloma Plasma Cells in the Bone Marrow Microenvironment.
    Hewett DR; Vandyke K; Lawrence DM; Friend N; Noll JE; Geoghegan JM; Croucher PI; Zannettino ACW
    Neoplasia; 2017 Dec; 19(12):972-981. PubMed ID: 29091798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of adhesion molecules in multiple myeloma.
    Cook G; Dumbar M; Franklin IM
    Acta Haematol; 1997; 97(1-2):81-9. PubMed ID: 8980613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Marrow Microenvironment in the Growth and Development of Malignant Plasma Cells in Multiple Myeloma.
    Giannakoulas N; Ntanasis-Stathopoulos I; Terpos E
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33923357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the bone marrow microenvironment in multiple myeloma.
    Roodman GD
    J Bone Miner Res; 2002 Nov; 17(11):1921-5. PubMed ID: 12412796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparanase promotes myeloma progression by inducing mesenchymal features and motility of myeloma cells.
    Li J; Pan Q; Rowan PD; Trotter TN; Peker D; Regal KM; Javed A; Suva LJ; Yang Y
    Oncotarget; 2016 Mar; 7(10):11299-309. PubMed ID: 26849235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioactivity and prognostic significance of growth differentiation factor GDF15 secreted by bone marrow mesenchymal stem cells in multiple myeloma.
    Corre J; Labat E; Espagnolle N; Hébraud B; Avet-Loiseau H; Roussel M; Huynh A; Gadelorge M; Cordelier P; Klein B; Moreau P; Facon T; Fournié JJ; Attal M; Bourin P
    Cancer Res; 2012 Mar; 72(6):1395-406. PubMed ID: 22301101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow angiogenesis in multiple myeloma.
    Vacca A; Ribatti D
    Leukemia; 2006 Feb; 20(2):193-9. PubMed ID: 16357836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow vascular niche and the control of angiogenesis in multiple myeloma.
    Ribatti D; Basile A; Ruggieri S; Vacca A
    Front Biosci (Landmark Ed); 2014 Jan; 19(2):304-11. PubMed ID: 24389186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling multiple myeloma-bone marrow interactions and response to drugs in a 3D surrogate microenvironment.
    Belloni D; Heltai S; Ponzoni M; Villa A; Vergani B; Pecciarini L; Marcatti M; Girlanda S; Tonon G; Ciceri F; Caligaris-Cappio F; Ferrarini M; Ferrero E
    Haematologica; 2018 Apr; 103(4):707-716. PubMed ID: 29326121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ROBO1 Promotes Homing, Dissemination, and Survival of Multiple Myeloma within the Bone Marrow Microenvironment.
    Bianchi G; Czarnecki PG; Ho M; Roccaro AM; Sacco A; Kawano Y; Gullà A; Samur AA; Chen T; Wen K; Tai YT; Moscvin M; Wu X; Camci-Unal G; Da Vià MC; Bolli N; Sewastianik T; Carrasco RD; Ghobrial IM; Anderson KC
    Blood Cancer Discov; 2021 Jul; 2(4):338-353. PubMed ID: 34268498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NRF2 Is One of the Players Involved in Bone Marrow Mediated Drug Resistance in Multiple Myeloma.
    Yen CH; Hsiao HH
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30405034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Old and Young Actors Playing Novel Roles in the Drama of Multiple Myeloma Bone Marrow Microenvironment Dependent Drug Resistance.
    Manni S; Carrino M; Semenzato G; Piazza F
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29783691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homing mechanisms in the biology of multiple myeloma.
    Van Camp B; Van Riet I
    Verh K Acad Geneeskd Belg; 1998; 60(3):163-94. PubMed ID: 9803879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microfluidic device engineered to study the trafficking of multiple myeloma cancer cells through the sinusoidal niche of bone marrow.
    Sui C; Zilberberg J; Lee W
    Sci Rep; 2022 Jan; 12(1):1439. PubMed ID: 35087109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.